T2DM rats showed increased levels of TGF-β and p-Smad3 when compared with control rats, while C3aRA treatment reduced both TGF-β and p-Smad3 level in T2DM rats (Figure 6). This evidence concerns the gene TGFB1 and type 2 diabetes mellitus.